The emergence of gene therapy and other transformative therapies has magnified concerns about affordability among payers, providers and patients. In this report, I assess novel payment innovation such as performance contracts, annuities, reinsurance/stop loss, and subscription models.
Neumann U. (2020). Innovative Financing for Novel Therapies. Certara.
Comments